Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya H Buch

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Arthritis Research & Therapy|November 26, 2008
Abatacept in the treatment of rheumatoid arthritisMaya H Buch, Edward M Vital, Paul Emery
Annals of the Rheumatic Diseases|January 14, 2022
Managing the selection of placebo group switched to experimental treatment group in post-randomised controlled trial extension studiesMaya H Buch, Walter P Maksymowych, Maarten Boers
Rheumatology (Oxford, England)|October 16, 2024
Initial survey of UK rheumatologists to inform a national cardio-rheumatology strategyAmr Mohammed, Rudresh Shukla, Simon Fisher, et al.
Nature Reviews. Rheumatology|February 6, 2013
Creative trial design in RA: optimizing patient outcomesMaya H Buch, Sue Pavitt, Mahesh Parmar, et al.
The Lancet. Rheumatology|August 20, 2025
Including refractory systemic sclerosis-associated GAVE in research agendasRushab C Shah, Laura J Ross, Maya H Buch
Nature Reviews. Rheumatology|September 5, 2020
Transforming clinical trials in rheumatology: towards patient-centric precision medicineCostantino Pitzalis, Ernest H S Choy, Maya H Buch
Current Opinion in Rheumatology|April 4, 2009
Costimulation blockade in rheumatic diseases: where we are?Vincent Goëb, Maya H Buch, Edward M Vital, et al.
Rheumatology (Oxford, England)|December 13, 2016
Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working groupLesley-Anne Bissell, Md Yuzaiful Md Yusof, Maya H Buch
Frontiers in Medicine|April 4, 2019
Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified TherapyLylia Ouboussad, Agata N Burska, Andrew Melville, et al.
Current Rheumatology Reports|August 21, 2015
B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During UseMd Yuzaiful Md Yusof, Edward M Vital, Maya H Buch
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Arthritis Research & Therapy|November 26, 2008
Abatacept in the treatment of rheumatoid arthritisMaya H Buch, Edward M Vital, Paul Emery
Annals of the Rheumatic Diseases|January 14, 2022
Managing the selection of placebo group switched to experimental treatment group in post-randomised controlled trial extension studiesMaya H Buch, Walter P Maksymowych, Maarten Boers
Rheumatology (Oxford, England)|October 16, 2024
Initial survey of UK rheumatologists to inform a national cardio-rheumatology strategyAmr Mohammed, Rudresh Shukla, Simon Fisher, et al.
Nature Reviews. Rheumatology|February 6, 2013
Creative trial design in RA: optimizing patient outcomesMaya H Buch, Sue Pavitt, Mahesh Parmar, et al.
The Lancet. Rheumatology|August 20, 2025
Including refractory systemic sclerosis-associated GAVE in research agendasRushab C Shah, Laura J Ross, Maya H Buch
Nature Reviews. Rheumatology|September 5, 2020
Transforming clinical trials in rheumatology: towards patient-centric precision medicineCostantino Pitzalis, Ernest H S Choy, Maya H Buch
Current Opinion in Rheumatology|April 4, 2009
Costimulation blockade in rheumatic diseases: where we are?Vincent Goëb, Maya H Buch, Edward M Vital, et al.
Rheumatology (Oxford, England)|December 13, 2016
Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working groupLesley-Anne Bissell, Md Yuzaiful Md Yusof, Maya H Buch
Frontiers in Medicine|April 4, 2019
Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified TherapyLylia Ouboussad, Agata N Burska, Andrew Melville, et al.
Current Rheumatology Reports|August 21, 2015
B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During UseMd Yuzaiful Md Yusof, Edward M Vital, Maya H Buch
Pageof 18